R&D
Envafolimab, the First Subcutaneously Administered PD-L1 Antibody for HBV Enters Phase IIb Study
2020-12-07
Agios Pharmaceuticals’ Lead Candidate Mitapivat Achieves Primary Endpoint in ACTIVATE Trial
2020-12-03
In Vivo Functional Screen, PerturbSeq Helps Understand the Complex Interplay of Autism Risk Genes
2020-12-01